Alto Neuroscience, Inc. share price logo

Alto Neuroscience, Inc.

NYSE: ANRO

Small Cap

$22.95

-1.68

(-6.82%)

Live

as on

Alto Neuroscience, Inc. Stock Performance

as on May 14, 2026 at 4:06 am IST

  • Day's Low

    Day's High

    $22.30
    $23.99
    downward going graph

    2.83%

    Downside

    4.53%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.15
    $28.44
    downward going graph

    90.63%

    Downside

    23.93%

    Upside

    downward going graph

Alto Neuroscience, Inc. share price movements today

Previous Close
$24.63
Open
$23.92
Volume
371.1K
Day's Low - High
$22.30 - $23.99
52 Week Low - High
$2.15 - $28.44

Alto Neuroscience, Inc. Historical Returns

1 Month Return
-4.35 %
3 Month Return
+ 45.83 %
1 Year Return
+ 939.24 %
3 Year Return
0 %
5 Year Return
0 %

Alto Neuroscience, Inc. Stock Fundamentals & Key Indicators

Check Alto Neuroscience, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$859.8M

EPS (TTM)

-2.2489

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-65.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-41.80%

Alto Neuroscience, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alto Neuroscience, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Alto Neuroscience, Inc. image
Alto Neuroscience, Inc.
BUY$859.8MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$38.0B119.7%71.3912.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.7BNA71.448.94%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.4B109.14%25.8435.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$74.7B39.88%17.3929.65%

Stock Returns calculator for Alto Neuroscience, Inc. Stock including INR - Dollar returns

The Alto Neuroscience, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Alto Neuroscience, Inc. investment value today

Current value as on today

₹10,86,800

Returns

₹9,86,800

(+986.8%)

Returns from Alto Neuroscience, Inc. Stock

₹8,68,354 (+868.35%)

Dollar Impact

₹1,18,446 (+118.45%)

Analyst Recommendation on Alto Neuroscience, Inc. Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Alto Neuroscience, Inc.. Average target price of $35.24

Alto Neuroscience, Inc. Share Price Target

Get share price movements and forecasts by analysts on Alto Neuroscience, Inc..

What analysts predicted

34.88%UPSIDE

Target Price

$35.24

Current Price

$22.95

Analyzed by

11 Analysts

Target

$35.24

Alto Neuroscience, Inc. target price $35.24, a slight upside of 34.88% compared to current price of $22.95. According to 11 analysts rating.

Indian Investors' Interest in Alto Neuroscience, Inc. Stock

Search interest for Alto Neuroscience, Inc. Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:7% versus previous 30 day period

Alto Neuroscience, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
0
-
-
-
0
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-9
-11
-14
-18
-18
-16
-15
-18
-14
-17
EBITDA
-8
-10
-12
-15
-16
-14
-14
-16
-13
-16
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-9
-11
-13
-16
-16
-15
-15
-17
-14
-16
Income Tax Expense
0
0
-
0
-
-
-
-
-
-
Net Income
-9
-11
-13
-16
-16
-15
-15
-17
-14
-16
Net Profit Margin
0.00%
-3015.32%
0.00%
0.00%
0.00%
-3858.12%
0.00%
0.00%
0.00%
0.00%

Alto Neuroscience, Inc. Annual Profit & Loss

All numbers in Millions USD

Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Total Revenue
0
-
-
-
-
Gross Profit
0
0
0
0
0
Operating Income
-12
-29
-37
-68
-66
EBITDA
-9
-27
-34
-68
-65
Interest Expense
-
-
1
-1
2
Depreciation
0
0
0
0
0
Income Before Tax
-9
-27
-36
-61
-63
Income Tax Expense
-
-
-
-61
-
Net Income
-9
-27
-36
-61
-63
Net Profit Margin
-4374.76%
0.00%
0.00%
0.00%
0.00%

Alto Neuroscience, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-11
-13
-16
-16
-15
-15
-17
-14
-16
Operating Cash Flow
-11
-10
-11
-11
-13
-16
-13
-9
-11
Investing Cash Flow
0
0
0
-1
0
0
-
-
-
Financing Cash Flow
43
134
0
1
0
9
0
0
50
Change in Cash
31
123
-12
-11
-13
-7
-13
-9
38

Alto Neuroscience, Inc. Annual Cash Flow

All numbers in Millions USD

Sep 2022
Sep 2023
Sep 2024
Sep 2025
Net Income
-27
-36
-61
-63
Operating Cash Flow
-20
-33
-47
-51
Investing Cash Flow
0
0
-2
0
Financing Cash Flow
43
68
135
60
Change in Cash
22
34
86
8

Alto Neuroscience, Inc. News & Key Events

  • img

    Today's Timeline - 13 January

    Tue, 07:21 PM

    -

    Alto Neuroscience presents new data validating Theta-ITC as a key EEG biomarker at the ACNP annual meeting.

Insights on Alto Neuroscience, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ANRO has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, ANRO stock has moved up by 939.2%

About Alto Neuroscience, Inc.

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties, which is in Phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor that is in Phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist, which is in Phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor that is in Phase 1 clinical trial for the treatment of MDD; and ALTO-208, a fixed-dose combination of pramipexole and aprepitant, an antiemetic, neurokinin-1 (NK-1) receptor antagonist for patients with Parkinson's disease for patients with Parkinson's disease. The company was incorporated in 2019 and is headquartered in Mountain View, California.
OrganisationAlto Neuroscience, Inc.
Headquarters650 Castro Street, Mountain View, CA, United States, 94041
IndustryBiotechnology
CEODr. Amit Etkin M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Alto Neuroscience, Inc.

Name

Title

Mr. Michael C. Hanley M.B.A.

Chief Operating Officer

Mr. Dan Segal B.Sc. (Hons), BCom, CA, MSc

Co-Founder & Strategic Advisor

Ms. Erin R. McQuade J.D.

General Counsel, Chief Administrative Officer & Corporate Secretary

Mr. Adam Savitz M.D., Ph.D.

Chief Medical Officer

Ms. Jessica Powell

Chief Development Officer

Dr. Amit Etkin M.D., Ph.D.

Founder, Chairman of the Board, CEO & President

Mr. Nicholas C. Smith

CFO & Chief Business Officer

FAQs

What is Alto Neuroscience, Inc. share price today?

Alto Neuroscience, Inc. share price today is $22.95 as on . Alto Neuroscience, Inc. share today touched a day high of $23.99 and a low of $22.3.

What is the 52 week high and 52 week low for Alto Neuroscience, Inc. share?

Alto Neuroscience, Inc. share touched a 52 week high of $28.44 on and a 52 week low of $2.15 on . Alto Neuroscience, Inc. stock price today i.e. is trending at $22.95,which is 19.31% down from its 52 week high and 967.44% up from its 52 week low.

What is Alto Neuroscience, Inc.'s market capitalisation today?

Alto Neuroscience, Inc. market capitalisation is $0.00T as on .

How to invest in Alto Neuroscience, Inc. Stock (ANRO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alto Neuroscience, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alto Neuroscience, Inc. Shares that will get you 0.0654 shares as per Alto Neuroscience, Inc. share price of $22.95 per share as on May 13, 2026 at 10:36 pm IST.

What is the minimum amount required to buy Alto Neuroscience, Inc. Stock (ANRO) from India?

Indian investors can start investing in Alto Neuroscience, Inc. (ANRO) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Alto Neuroscience, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Alto Neuroscience, Inc. share’s latest price of $22.95 as on May 13, 2026 at 10:36 pm IST, you will get 0.4357 shares of Alto Neuroscience, Inc.. Learn more about fractional shares .